Key facts
- Notable investors include Galion.exe.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EPICS Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for EPICS Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EPICS Biotechnology
Producer of plant-derived biopesticides and biostimulants intended to support a sustainable and cost-effective crop input market. The company offers a seed-based expression system that naturally produces value bioactives at scale, enabling clients to get a sustainable and cost-effective crop input market by reducing reliance on chemical inputs and addressing resistance challenges.
- Sector
- Materials and Resources
- HQ
- Évry-Courcouronnes, France
- Founded
- 2025
- Employees
- 5
- Website
- epicsbiotech.com/
- Ownership
- Privately Held (backing)
EPICS Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EPICS Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EPICS Biotechnology in its N-PORT filings yet. We sweep new filings monthly.